VivoSeq
Other

Oral

0

Pipeline Programs↗

50

Active Trials↗

163

Companies Involved↗

Oral is an early-stage landscape with 0 programs across 163 companies. The most active players are Boehringer Ingelheim, Pfizer, AstraZeneca.

Intelligence

Pipeline Metrics

Competitive Density

49/100

Pipeline Velocity

49/100

Mech. Concentration

N/A

Completion Rate

92/100

Attrition Rate

7/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Boehringer Ingelheim logo

Boehringer Ingelheim

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalGSK logo

GSK

0 programs

PreclinicalBayer logo

Bayer

0 programs

PreclinicalJohnson & Johnson logo

Johnson & Johnson

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

961

clinical trials

Completed799 · 83%
Terminated45 · 5%
Unknown status44 · 5%
Recruiting27 · 3%
Withdrawn19 · 2%
Not yet recruiting10 · 1%
Other17 · 2%

Clinical Trials

Trial Activity

961 trials

A Study of Oral Kavalactones Effect on Nurses
Recruiting·MMayo Clinic·N/A·NCT06177535·200 enrolled
Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study
Recruiting·UUniversity of Electronic Science and Technology of China·N/A·NCT06329063·80 enrolled
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years
Recruiting·AActio Biosciences, Inc.·Phase 1·NCT07156201·74 enrolled
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Recruiting·AAOP Orphan Pharmaceuticals AG·Phase 4·NCT06317805·110 enrolled
Studying Flavors and Cooling Agents in Oral Nicotine Pouches to Understand User Preferences
Recruiting·OOhio State University Comprehensive Cancer Center·N/A·NCT07111234·30 enrolled
Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers
Recruiting·VValenta Pharm JSC·Phase 1·NCT06859333·36 enrolled
Oral Hyoscine vs. Topical EMLA vs. Placebo for Pain Reduction During Hysterosalpingography
Recruiting·—·N/A·NCT07383571·102 enrolled
Oral Contraceptive Pill (OCP) Pharmacogenomics
Recruiting·YYale University·Phase 4·NCT06334315·700 enrolled
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic Enzymes
Recruiting·CChengdu Suncadia Medicine Co., Ltd.·Phase 1·NCT07230418·66 enrolled
Behavioral Pharmacology of Orally Administered THC and D-limonene
Recruiting·JJohns Hopkins University·Phase 1·NCT06378957·65 enrolled
Single-centre Descriptive Study of Taste in Frontotemporal Lobar Degeneration Through the Analysis of Taste Evoked Potentials
Recruiting·—·N/A·NCT07110207·20 enrolled
Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
Recruiting·—·Phase 2·NCT04804007·64 enrolled
CRACK-TARGET 1: Descriptive Study of Observed Behavioral Sensitization and Expectations
Recruiting·AAssistance Publique - Hôpitaux de Paris·N/A·NCT06050304·20 enrolled
A Study to Assess the Pharmacokinetics of GEn-1124 After Single Oral Dosing in Healthy Subjects
Recruiting·GGEn1E Lifesciences·Phase 1·NCT07185113·6 enrolled
Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.
Recruiting·VValenta Pharm JSC·Phase 1·NCT07421011·36 enrolled
Page 1 of 65

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)